GUARDANT HEALTH INC · held by 1 fund · data as of 2026-06-03
Sector
Healthcare
Industry
Diagnostics & Research
Market cap
$17.26B
Price
$129.33
12-mo
+169.10%
Held by
1 fund
Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company offers Guardant360 CDx test, a liquid biopsy test for tumor mutation profiling; Guardant360 Liquid test, which measures 740+ genes and supports all guideline-recommended biomarkers; Guardant Reveal test, a blood test that utilizes circulating tumor DNA to detect cancer at the molecular level; and Guardant360 Tissue test, a molecular profiling test for tumor tissue that provides genomic, transcriptomic, and epigenomic insights. It also provide…